Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-11-15

Clinical Trial Update: Treating Primary Sclerosing Cholangitis and Biliary Atresia With Vancomycin [Phase 1]

View source ↗

Summary

Phase 1 clinical trial investigating vancomycin for primary sclerosing cholangitis and biliary atresia; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vancomycin (vancomycin)

Snippet

Sponsor: Sacramento Pediatric Gastroenterology | Conditions: Primary Sclerosing Cholangitis, Biliary Atresia | Phase 1 | Status: RECRUITING